BioSpace News Archive

Genetown

Evelo Biosciences Announces Issuance of U.S. Patent Supporting Monoclonal Microbial Oncology Trials

Evelo announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 9,855,302 covering Bifidobacteria for the treatment of cancer in combination with checkpoint inhibitors.

January 9, 2018
·
4 min read
TTP Ventus Micropump Technology Enables Wearable Treatment for Sleep Apnea

Having recently received a Health Canada Medical Device License, aerSleep is now approved for marketing to patients in Canada. CE mark approval is expected Q4 2018.

January 9, 2018
·
2 min read
FDA

Cepheid Receives FDA Clearance and CLIA Waiver for Xpert Xpress Flu Test

The Xpert Xpress Flu test is also indicated for use with nasal swabs, in addition to nasopharyngeal swabs.

January 9, 2018
·
2 min read
Business

SCORR Marketing and Applied Clinical Trials Release Report on Clinical Research Industry Salary and Employee Satisfaction

The report, produced in partnership with Applied Clinical Trials, is based on a survey of its subscribers working at pharmaceutical and biotech companies, contract research organizations (CROs), research sites and academic institutions.

January 9, 2018
·
2 min read
Business

Orthofix Announces Preliminary 2017 Fourth Quarter and Full Year Net Sales Results

Orthofix today announced preliminary unaudited fourth quarter 2017 net sales of approximately $117 million.

January 9, 2018
·
11 min read
Biotech Bay

Exelixis to Co-Host Financial Community Briefing to Discuss Data Presented at the 2018 American Society of Clinical Oncology Gastrointestinal Cancers Symposium

The webcast event will be held following the closing of the ASCO-GI day’s sessions on Friday, January 19, 2018, beginning at 9:30 p.m. EST / 6:30 p.m. PST.

January 9, 2018
·
3 min read
Policy

Pulmonx Submits Premarket Approval (PMA) Application to U.S. FDA for Zephyr Endobronchial Valve as Treatment for Emphysema

The filing was based on the successful execution of Pulmonx’s pivotal IDE trial, the LIBERATE Study, a landmark randomized controlled trial that enrolled 190 patients with severe emphysema at 24 centers in the U.S. and Europe.

January 9, 2018
·
4 min read
Business

Radient Technologies Inc. Provides Corporate Update and Announces Real Estate Expansion

The Facility is fully GMP compliant with a pending ACMPR license expected to be issued by Health Canada later this year.

January 9, 2018
·
7 min read
ESSA Completes $21M Equity Offering

Pursuant to the Concurrent Private Placement, the Company issued 3,375,000 Common Shares at the Offering Price to certain directors of the Company for additional aggregate gross proceeds of US$675,000.

January 9, 2018
·
6 min read
Drug Development

Emotional Brain’s FSIAD Products Lybrido and Lybridos Show High Efficacy and Safety in Phase IIb Trials

Emotional Brain is pleased to announce the publication of positive phase 2B results in the authoritative Journal of Sexual Medicine.

January 9, 2018
·
1 min read